LOUISVILLE, Colo., Sept. 25, 2024 /PRNewswire/ — Synergy Spine Solutions Ltd, an innovative orthopedic medical device developer focused on artificial cervical disc replacement, today announced that it has completed patient enrollment in its U.S. 2-Level IDE clinical trial. Conducted under a U.S. Investigational Device Exemption (IDE), the 2-Level trial will evaluate the safety and effectiveness of the Synergy […]
Synergy Spine Solutions Announces $30M Financing
LOUISVILLE, Colorado, January 31, 2024 – Synergy Spine Solutions, an innovative medical device developer focused on artificial cervical disc replacement, announced today that it has closed on a significant equity financing of $30 million. The Series A financing was led by a new institutional investor, Amzak Health, and joined by other investors. The proceeds will […]
Synergy Spine Solutions Announces Strategic Collaboration with DePuy Synthes UK
Synergy Spine Solutions, an innovative orthopaedic medical devices developer focused on artificial cervical disc replacement, today announced it has entered into a sales agency agreement with DePuy Synthes Spine (DPS) to expand access to the company’s marquis technology, the Synergy Disc®, in the United Kingdom. The Synergy Disc® is the only artificial cervical disc with a 6° lordotic […]
Synergy Spine Solutions announces partnership with Ample Healthcare to distribute the Synergy Disc in Malaysia
Synergy Spine Solutions is pleased to announce a new partnership with leading independent medical device specialists Ample Healthcare, to distribute the Synergy Disc in Malaysia. Based in Kuala Lumpur and with a focus in spine and orthopaedic surgery, Ample Healthcare was launched in 2020 with the objective of providing international partners access to the Malaysian market. The […]
Synergy Spine Solutions Announces First Patient Enrolled in the Synergy Disc® 2-Level IDE Trial
Synergy Spine Solutions Ltd, an innovative orthopaedic medical device developer focused on artificial cervical disc replacement, today announced it has enrolled the first patient in its U.S. IDE 2-Level clinical trial. Conducted under a U.S. Investigational Device Exemption (IDE), the 2-Level trial will evaluate the safety and effectiveness of the Synergy Disc® artificial cervical disc […]
Synergy Spine Solutions Completes Enrollment of 1-Level IDE Trial
Synergy Spine Solutions Ltd, an innovative orthopaedic medical device developer focused on artificial cervical disc replacement, today announced it has completed enrollment in its first-ever IDE clinical trial. The 1-Level Synergy Disc IDE clinical trial (NCT 04469231) enrolled 175 patients in its multi-center, prospective, historically controlled pivotal trial comparing the safety and effectiveness of the Synergy […]
